Concentrates on deploying equity and structured capital into growth-stage technology and healthcare companies in North America, prioritizing revenue-scalable business models and board-level value creation. Nathan White brings prior experience in investment banking and growth equity, advising on M&A and capital raises, and draws on operational collaboration with founders to accelerate go-to-market and margin expansion.
Concentrates on deploying equity and structured capital into growth-stage technology and healthcare companies in North America, prioritizing revenue-scalable business models and board-level value creation. Nathan White brings prior experience in investment banking and growth equity, advising on M&A and capital raises, and draws on operational collaboration with founders to accelerate go-to-market and margin expansion.
Targets growth-stage technology and healthcare companies with revenue-scalable models, deploying a mix of equity and structured capital to align incentives and preserve optionality. Focuses on board-level collaboration to drive GTM acceleration, margin expansion and disciplined capital efficiency. Investment decisions emphasize unit economics, repeatable revenue and near-term monetization pathways, with a 3–7 year value-creation horizon and active governance to manage execution risk. Prefers North American opportunities where operational playbooks and M&A exit pathways are clear.
Targets growth-stage technology and healthcare companies with revenue-scalable models, deploying a mix of equity and structured capital to align incentives and preserve optionality. Focuses on board-level collaboration to drive GTM acceleration, margin expansion and disciplined capital efficiency. Investment decisions emphasize unit economics, repeatable revenue and near-term monetization pathways, with a 3–7 year value-creation horizon and active governance to manage execution risk. Prefers North American opportunities where operational playbooks and M&A exit pathways are clear.
| Trades 1158 | Longs Won 571/1158 49% | Profit Factor 1.46 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $167,930.16 |
| Average Win $87,320.11 | Best Trade (Jul 10) $2.08M | Sharpe Ratio -8.89 |
| Average Loss -$58,191.7 | Worst Trade (Jul 14) -$1.09M | Z-Score -10.31 (100%) |
| Commissions $0 | Avg. Trade Length 1y 3m 6d | Expectancy $13,558.94 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 2,151 | 1,935 | 1,720 | 1,505 | 1,290 | 1,075 | 860 | 645 | 430 | 215 |